ICER’s NASH Panel Shows Some Enthusiasm For Resmetirom, None For OCA

 
• By Joseph Haas
  
Apples to apples
Icer's reviewed two NASH drug candidates ahead of potential approval • Source: Shutterstock

More from New Products

More from Scrip